p.123 抽出テキスト

548-558. PMID: 27879313 442. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 2006; 355: 788- 798. PMID: 16928994 443. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994; 331: 689-694. PMID: 8058074 444. Evangelista A, Tornos P, Sambola A, et al. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005; 353: 1342-1349. PMID: 16192479 445. Elder DH, Wei L, Szwejkowski BR, et al. The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol 2011; 58: 2084-2091. PMID: 22051330 446. Zendaoui A, Lachance D, Roussel E, et al. Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation. Circ Heart Fail 2011; 4: 207-213. PMID: 21216836 447. Sampat U, Varadarajan P, Turk R, et al. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol 2009; 54: 452-457. PMID: 19628121 448. Teixido-Tura G, Forteza A, Rodríguez-Palomares J, et al. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome. J Am Coll Cardiol 2018; 72: 1613-1618. PMID: 30261963 449. Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart 2013; 99: 396-400. PMID: 22942293 450. Danielsen R, Aspelund T, Harris TB, et al. The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavík study. Int J Cardiol 2014; 176: 916-922. PMID: 25171970 451. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol 2010; 55: 2789-2800. PMID: 20579534 452. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111: 920-925. PMID: 15710758 453. Krepp JM, Roman MJ, Devereux RB, et al. GenTAC Investigators. Bicuspid and unicuspid aortic valves: Different phenotypes of the same disease? Insight from the GenTAC Registry. Congenit Heart Dis 2017; 12: 740-745. PMID: 28805011 454. Tsang MY, Abudiab MM, Ammash NM, et al. Quadricuspid Aortic Valve: Characteristics, Associated Structural Cardiovascular Abnormalities, and Clinical Outcomes. Circulation 2016; 133: 312-319. PMID: 26635401 455. Ito S, Miranda WR, Nkomo VT, et al. Reduced Left Ventricular Ejection Fraction in Patients With Aortic Stenosis. J Am Coll Cardiol 2018; 71: 1313-1321. PMID: 29566814 456. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol 2012; 60: 1854- 1863. PMID: 23062541 457. Akahori H, Tsujino T, Naito Y, et al. Intraleaflet haemorrhage is associated with rapid progression of degenerative aortic valve stenosis. Eur Heart J 2011; 32: 888-896. PMID: 21193435 458. Yamamoto K, Yamamoto H, Takeuchi M, et al. Risk Factors for Progression of Degenerative Aortic Valve Disease in the Japanese- The Japanese Aortic Stenosis Study (JASS) Prospective Analysis. Circ J 2015; 79: 2050-2057. PMID: 26134576 459. Novaro GM, Katz R, Aviles RJ, et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007; 50: 1992-1998. PMID: 17996566 460. Faggiano P, Antonini-Canterin F, Erlicher A, et al. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol 2003; 91: 99-101. PMID: 12505585 461. Ortlepp JR, Schmitz F, Mevissen V, et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J 2004; 25: 514-522. PMID: 15039132 462. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29: 630-634. PMID: 9060903 463. Cowell SJ, Newby DE, Prescott RJ, et al. Scottish Aortic Stenosis

and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352: 2389-2397. PMID: 15944423 464. Rossebø AB, Pedersen TR, Boman K, et al. SEAS Investigators. In-

tensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343-1356. PMID: 18765433 465. Chan KL, Teo K, Dumesnil JG, et al. ASTRONOMER Investigators. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010; 121: 306-314. PMID: 20048204 466. Cairns BJ, Coffey S, Travis RC, et al. A Replicated, Genome-Wide Significant Association of Aortic Stenosis With a Genetic Variant for Lipoprotein(a): Meta-Analysis of Published and Novel Data. Circulation 2017; 135: 1181-1183. PMID: 28320808 467. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38 Suppl: 61-67. PMID: 4894151 468. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988; 9 Suppl: 57-64. PMID: 3042404 469. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611- 617. PMID: 10965007 470. Rosenhek R, Zilberszac R, Schemper M, et al. Natural history of very severe aortic stenosis. Circulation 2010; 121: 151-156. PMID: 20026771 471. Lancellotti P, Magne J, Dulgheru R, et al. Outcomes of Patients With Asymptomatic Aortic Stenosis Followed Up in Heart Valve Clinics. JAMA Cardiol 2018; 3: 1060-1068. PMID: 30285058 472. Kang DH, Park SJ, Rim JH, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010; 121: 1502-1509. PMID: 20308614 473. Taniguchi T, Morimoto T, Shiomi H, et al. CURRENT AS Registry Investigators. Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis. J Am Coll Cardiol 2015; 66: 2827-2838. PMID: 26477634 474. Bohbot Y, de Meester de Ravenstein C, Chadha G, et al. Relationship Between Left Ventricular Ejection Fraction and Mortality in Asymptomatic and Minimally Symptomatic Patients With Severe Aortic Stenosis. JACC Cardiovasc Imaging 2019; 12: 38-48. PMID: 30448114 475. Noly PE, Basmadjian L, Bouhout I, et al. New Insights Into Unicuspid Aortic Valve Disease in Adults: Not Just a Subtype of Bicuspid Aortic Valves. Can J Cardiol 2016; 32: 110-116. PMID: 26724514 476. Michelena HI, Prakash SK, Della Corte A, et al. BAVCon Investigators. Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). Circulation 2014; 129: 2691-2704. PMID: 24958752 477. Kwon MH, Sundt TM. Bicuspid Aortic Valvulopathy and Associated Aortopathy: a Review of Contemporary Studies Relevant to Clinical Decision-Making. Curr Treat Options Cardiovasc Med 2017; 19: 68. PMID: 28780662 478. Thaden JJ, Nkomo VT, Lee KJ, et al. Doppler Imaging in Aortic Stenosis: The Importance of the Nonapical Imaging Windows to Determine Severity in a Contemporary Cohort. J Am Soc Echocardiogr 2015; 28: 780-785. PMID: 25857547 479. Magne J, Lancellotti P, Piérard LA. Exercise testing in asymptomatic severe aortic stenosis. JACC Cardiovasc Imaging 2014; 7: 188-199. PMID: 24524744 480. Stefanini GG, Stortecky S, Cao D, et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur Heart J 2014; 35: 2530-2540. PMID: 24682843 481. Davies JE, Piek JJ. Time for caution interpreting coronary physiology in aortic stenosis? EuroIntervention 2018; 14: 132-134. PMID: 29937425 482. Yamanaka F, Shishido K, Ochiai T, et al. Instantaneous Wave-Free Ratio for the Assessment of Intermediate Coronary Artery Stenosis in Patients With Severe Aortic Valve Stenosis: Comparison With Myocardial Perfusion Scintigraphy. JACC Cardiovasc Interv 2018; 11: 2032-2040. PMID: 30154064 483. Clavel MA, Pibarot P, Messika-Zeitoun D, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol 2014; 64: 1202-1213. PMID: 25236511 484. Kakefuda Y, Hayashida K, Yamada Y, et al. Impact of Subclinical Vascular Complications Detected by Systematic Postprocedural Multidetector Computed Tomography After Transcatheter Aortic Valve Implantation Using Balloon-Expandable Edwards SAPIEN XT Heart Valve. Am J Cardiol 2017; 119: 1100-1105. PMID: 28162223 485. Minners J, Allgeier M, Gohlke-Baerwolf C, et al. Inconsistencies of

echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J 2008; 29: 1043-1048. PMID: 18156619